CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,574,000 | -50.9% | 152,964 | -51.7% | 0.02% | -48.3% |
| Q3 2016 | $3,205,000 | -39.3% | 316,976 | -32.6% | 0.03% | -47.3% |
| Q2 2016 | $5,279,000 | -22.1% | 470,058 | -5.2% | 0.06% | -22.5% |
| Q1 2016 | $6,774,000 | -28.0% | 495,908 | 0.0% | 0.07% | -9.0% |
| Q4 2015 | $9,407,000 | +1.1% | 495,908 | 0.0% | 0.08% | -9.3% |
| Q3 2015 | $9,308,000 | +26.1% | 495,908 | 0.0% | 0.09% | +32.3% |
| Q2 2015 | $7,384,000 | -1.7% | 495,908 | 0.0% | 0.06% | +4.8% |
| Q1 2015 | $7,511,000 | +11.6% | 495,908 | -1.9% | 0.06% | -10.1% |
| Q4 2014 | $6,732,000 | +18.3% | 505,418 | +11.9% | 0.07% | -4.2% |
| Q3 2014 | $5,693,000 | +41.3% | 451,496 | +13.2% | 0.07% | +46.9% |
| Q2 2014 | $4,028,000 | – | 398,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |